Jane Street’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMLX
SVCM
Jane Street's AMLX Position: Q3 2026 in Review
Jane Street increased its Amylyx Pharmaceuticals (AMLX) stake by 145% in Q3 2026, buying an estimated $11.5M and bringing the position to 735,231 shares worth $21.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2028.
Jane Street first reported a position in AMLX in Q1 2022 and has held it in 16 quarters since. 230 funds tracked by Wall St. Rank hold AMLX as of Q3 2026.
- Jane Street held 735,231 shares of Amylyx Pharmaceuticals worth $21.4M as of Q3 2026.
- Jane Street bought 435,666 Amylyx Pharmaceuticals shares in Q3 2026, an estimated $11.5M.
- Amylyx Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #2028 holding.
- Jane Street first reported a position in Amylyx Pharmaceuticals in Q1 2022 and has held it in 16 quarters since.
- 230 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q3 2026.
Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.